High-Grade Squamous Intraepithelial Lesion
Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.
What High-Grade Squamous Intraepithelial Lesion Means
High-Grade Squamous Intraepithelial Lesion, often called HSIL, refers to areas of abnormal cells found on the surface of the cervix. These cells look moderately to severely abnormal when examined under a microscope. HSIL is usually caused by a long-lasting infection with certain types of human papillomavirus (HPV), a common virus that can affect the cervix. HSIL is sometimes called moderate or severe dysplasia, which means the cells have changed enough that they could develop into cancer if not treated.
Why HSIL Matters in Cancer Care
HSIL is important because it signals a higher risk of cervical cancer developing in the future. While HSIL itself is not cancer, it shows that the cells are abnormal enough to need attention. If left untreated, these abnormal cells may grow and spread into nearby tissues, potentially becoming invasive cancer. Detecting HSIL early through regular Pap tests allows doctors to monitor or treat the changes before cancer develops.
What Patients Might See or Hear About HSIL
If your Pap test report mentions HSIL, it means some cervical cells look seriously abnormal. Sometimes, the report might say “Atypical Squamous Cells, Cannot Exclude a High-Grade Lesion” (ASC-H), which means the lab found abnormal cells that could be HSIL but isn’t certain. Your healthcare provider will likely recommend further testing, such as a colposcopy—a procedure that uses a special microscope to look closely at the cervix—and possibly a biopsy, where a small tissue sample is taken to confirm the diagnosis. It’s important to know that HSIL does not mean you have cancer, but it does mean your doctor wants to check carefully and may suggest treatment to prevent cancer.
How Doctors Use HSIL in Diagnosis and Follow-Up
When HSIL is found on a Pap test, doctors usually recommend follow-up tests to confirm the diagnosis and decide on treatment. A colposcopy allows the doctor to examine the cervix closely and take biopsies if needed. If HSIL is confirmed, treatment often involves removing or destroying the abnormal cells to prevent progression to cancer. Common treatments include procedures like LEEP (loop electrosurgical excision procedure), cryotherapy, or laser ablation. These treatments are effective in removing abnormal cells and lowering the risk of cervical cancer.
Related Terms and Common Confusions
HSIL is part of a group of terms used to describe abnormal cervical cells found on Pap tests. It is more serious than low-grade squamous intraepithelial lesion (LSIL), which usually involves milder changes that often go away on their own. Another related term is ASC-H, which means “Atypical Squamous Cells, Cannot Exclude a High-Grade Lesion.” ASC-H suggests abnormal cells that might be HSIL but need further testing to be sure. Understanding these terms can help you follow your care plan and know why your doctor recommends certain tests or treatments.
What HSIL Does Not Automatically Mean
Receiving a result of HSIL or ASC-H does not mean you have cervical cancer. These terms describe abnormal cells that could become cancer if untreated but are not cancer themselves. Many people with HSIL receive treatment that successfully removes the abnormal cells and prevents cancer from developing. It’s important to follow your healthcare provider’s recommendations for follow-up and treatment to protect your health.
Next Steps and Safety Information
If your test results mention HSIL or ASC-H, the best next step is to talk with your healthcare provider about what the results mean for you. They can explain what follow-up tests or treatments are recommended and answer your questions. Regular cervical cancer screening and timely follow-up of abnormal results are key to preventing cervical cancer. This information is educational and does not replace personalized medical advice. Always discuss your specific situation with your care team.
Sources
Public source information used for this glossary entry includes: